Felten R - Search Results

1

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab.

Felten R, Gallais F, Schleiss C, Chatelus E, Javier RM, Pijnenburg L, Sordet C, Sibilia J, Arnaud L, Fafi-Kremer S, Gottenberg JE. Felten R, et al. Lancet Rheumatol. 2022 Jan;4(1):e13-e16. doi: 10.1016/S2665-9913(21)00351-9. Epub 2021 Nov 8. Lancet Rheumatol. 2022. PMID: 34778844 Free PMC article. No abstract available.

2

The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials.

Felten R, Dervovic E, Chasset F, Gottenberg JE, Sibilia J, Scher F, Arnaud L. Felten R, et al. Autoimmun Rev. 2018 Aug;17(8):781-790. doi: 10.1016/j.autrev.2018.02.011. Epub 2018 Jun 6. Autoimmun Rev. 2018. PMID: 29885544 Review.

3

Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells.

Sawaf M, Fauny JD, Felten R, Sagez F, Gottenberg JE, Dumortier H, Monneaux F. Sawaf M, et al. Among authors: felten r. JCI Insight. 2018 Jul 12;3(13):e99711. doi: 10.1172/jci.insight.99711. JCI Insight. 2018. PMID: 29997289 Free PMC article.

4

Advances in the treatment of systemic lupus erythematosus: From back to the future, to the future and beyond.

Felten R, Scher F, Sibilia J, Chasset F, Arnaud L. Felten R, et al. Joint Bone Spine. 2019 Jul;86(4):429-436. doi: 10.1016/j.jbspin.2018.09.004. Epub 2018 Sep 19. Joint Bone Spine. 2019. PMID: 30243784 Review.

5

10 most important contemporary challenges in the management of SLE.

Felten R, Sagez F, Gavand PE, Martin T, Korganow AS, Sordet C, Javier RM, Soulas-Sprauel P, Rivière M, Scher F, Poindron V, Guffroy A, Arnaud L. Felten R, et al. Lupus Sci Med. 2019 Jan 10;6(1):e000303. doi: 10.1136/lupus-2018-000303. eCollection 2019. Lupus Sci Med. 2019. PMID: 30729019 Free PMC article. Review.

6

Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism.

Felten R, Perrin P, Caillard S, Moulin B, Javier RM. Felten R, et al. PLoS One. 2019 Feb 22;14(2):e0212931. doi: 10.1371/journal.pone.0212931. eCollection 2019. PLoS One. 2019. PMID: 30794689 Free PMC article.

7

The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

Felten R, Scher F, Sibilia J, Gottenberg JE, Arnaud L. Felten R, et al. Autoimmun Rev. 2019 Jun;18(6):576-582. doi: 10.1016/j.autrev.2018.12.008. Epub 2019 Apr 6. Autoimmun Rev. 2019. PMID: 30959220

8

The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database.

Sebbag E, Felten R, Sagez F, Sibilia J, Devilliers H, Arnaud L. Sebbag E, et al. Among authors: felten r. Ann Rheum Dis. 2019 Jun;78(6):844-848. doi: 10.1136/annrheumdis-2019-215142. Epub 2019 Apr 15. Ann Rheum Dis. 2019. PMID: 30987966

9

Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date.

Felten R, Scher F, Sagez F, Chasset F, Arnaud L. Felten R, et al. Drug Des Devel Ther. 2019 May 8;13:1535-1543. doi: 10.2147/DDDT.S170969. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31190735 Free PMC article. Review.

10

[A review of avascular necrosis, of the hip and beyond].

Pijnenburg L, Felten R, Javier RM. Pijnenburg L, et al. Among authors: felten r. Rev Med Interne. 2020 Jan;41(1):27-36. doi: 10.1016/j.revmed.2019.10.332. Epub 2019 Nov 10. Rev Med Interne. 2020. PMID: 31722835 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page